The New York Times
CNN
Guardian
FDA panel recommends easing restrictions on several peptides, including BPC-157
Forbes contributors publish independent expert analyses and insights.
Robert F. Kennedy Jr., the Health and Human Services Secretary with a history of boosting unproven health claims, wants to expand public access to peptide injections.
In a series of votes, outside experts to the Food and Drug Administration advised the agency to drop current restrictions barring pharmacies from producing injectable peptides with names like BPC-157, TB-500 and KPV.
Peptides, a class of compounds increasingly marketed as wellness treatments, have exploded in popularity in recent years, moving from niche bodybuilding and biohacking circles to now being promoted for everything from weight loss to longevity.
